Post-ICU Consultation : a Time to Discuss Advance Directives (CoPRADA)

Completed

• Conditions: Advance Directives; Post Intensive Care Syndrome; Advance Care Planning

• Registration Number: NCT05817500
• Lead Sponsor: University Hospital, Brest

Brief Summary

The aim of this study is to assess the possibility of discussing advance directives during post-intensive care consultation.

Detailed Description

After a stay in intensive care units (ICU), patients can experience physical, psychological and cognitive impairments. To assess this post intensive care syndrom (PICS), post-ICU consultation have been developed.

Since 5 year mortality is higher in ICU survivors, it might be interesting to address those patients' views relating to illness and end of life through a discussion on advance directives (AD), during post-ICU consultation.

However, the development of these consultations being recent, it has not yet been assessed whether this consultations might be a suitable time to discuss AD and the intensivit a suitable interlocutor.

Study Timeline

• Study Start: 2021-12-09
• Primary Completion: 2022-12-09
• Study Completion: 2022-12-09
• Status Verified: 2023-04
• Study First Submitted: 2023-04-05
• Study First Submitted QC: 2023-04-17
• Last Update Submitted: 2023-04-17
• Study First Posted: 2023-04-18
• Last Update Posted: 2023-04-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Patients with 48 hours of mechanical ventilation
• Patients with a 5 days stay in ICU

Exclusion Criteria

• Patients with therapeutic limitation discussed during their ICU stay
• Geographical remotness to come to the post-ICU consultation
• Minor patients
• Patient not affiliated to the social security scheme

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patients willing to discuss AD after an ICU stay	1 year	Number of patient willing to discussion AD after ICU stay will be observed

Secondary Outcome Measures

Name	Time	Method
Number of patients knowing about AD before their ICU stay	1 year	Number of patient knowing before AD before ICU stay will be observed
Evaluation of the privileged interlocutor to complete AD	1 year	The privileged interlocutor to complete AD will be observed
Evaluation of the privileged interlocutor to discuss AD	1 year	The privileged interlocutor to discuss AD will be observed
Factors influencing the writing of AD after an ICU stay	1 year	Factors such as lenght of stay in ICU, lenght of hospitalisation, duration of mechanical ventilation /sedation and the existence of PTSD (PCLS) or anxiety/ depression (HADS) will be evaluated and their influence on the completion of AD

Trial Locations

Locations (1)

CHU Brest; 🇫🇷 Brest, France